These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 400121)

  • 1. [The sulfamethoxazole-trimethoprim combination 1st survey into its in vitro activity in brazzaville, Congo Results of 780 bacterial strains isolated at the National Laboratory and the General Hospital in a single year].
    Yala F
    Bull Soc Pathol Exot Filiales; 1979; 72(3):198-204. PubMed ID: 400121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
    Lebek G; Wiedmer E
    Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of in vitro antibacterial activities of the combination of trimethoprim and sulfamethoxazole on clinical isolates in Japan.
    J Infect Dis; 1973 Nov; 128():Suppl:502-7 p. PubMed ID: 4585955
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections].
    Joly B; Sirot D; Cluzel M; Chanal M; Bruneau D
    Pathol Biol (Paris); 1984 Jun; 32(6):689-92. PubMed ID: 6611536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.
    Fruensgaard K; Korner B
    Chemotherapy; 1974; 20(2):97-101. PubMed ID: 4210895
    [No Abstract]   [Full Text] [Related]  

  • 7. Trimethoprim-sulfamethoxazole: in vitro microbiological aspects.
    Bushby SR
    J Infect Dis; 1973 Nov; 128():Suppl:442-62 p. PubMed ID: 4585951
    [No Abstract]   [Full Text] [Related]  

  • 8. Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined.
    Bach MC; Finland M; Gold O; Wilcox C
    J Infect Dis; 1973 Nov; 128():Suppl:508-33 p. PubMed ID: 4148416
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectivity of a sulfonamide-trimethoprim combination against various gram-negative rods and gram-positive cocci in the agar diffusion test].
    Tiesler E
    Med Klin; 1970 Oct; 65(42):1825-8. PubMed ID: 4933237
    [No Abstract]   [Full Text] [Related]  

  • 10. [Laboratory findings on a combination of trimethoprim and sulfamethoxazole].
    Legler F
    Dtsch Med Wochenschr; 1971 May; 96(19):823-4 passim. PubMed ID: 4396839
    [No Abstract]   [Full Text] [Related]  

  • 11. Trimethoprim/sulphamethoxazole resistance in Escherichia coli and Klebsiella spp. urinary isolates.
    Obaseiki-Ebor EE
    Afr J Med Med Sci; 1988 Sep; 17(3):175-9. PubMed ID: 2845759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined action of sulphamethoxazole and trimethoprim against clinically-isolated sulphonamide-resistant bacteria.
    Grey D; Hamilton-Miller JM; Brumfitt W
    Chemotherapy; 1979; 25(5):296-302. PubMed ID: 383418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The resistance to antibiotics of strains of Streptococcus viridans, Streptococcus faecalis, Escherichia coli, Pseudomonas aeruginosa, Proteus and Klebsiella isolated in Poland.
    Jeljaszewicz J; Hawiger J
    Bull World Health Organ; 1966; 35(2):243-6. PubMed ID: 5332528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
    Unal S; Aydin M; Akin A
    Mikrobiyol Bul; 1988; 22(4):316-21. PubMed ID: 3266971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sulfamethoxazole-trimethoprim: bacteriological experiences after 5 years of use].
    Kayser FH; Santanam P
    Schweiz Med Wochenschr; 1974 Dec; 104(52):1950-4. PubMed ID: 4215133
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the microbial resistance to the drug combination sulfamethoxazole trimethroprim with special reference to enterococci].
    Gärtner H; Dieterich F
    Arzneimittelforschung; 1973 Apr; 23(4):597-600. PubMed ID: 4197072
    [No Abstract]   [Full Text] [Related]  

  • 17. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
    Murray BE; Rensimer ER; DuPont HL
    N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bactericidal activity "in vitro" of sulfamethoxazol-tri-methoprime (SMZ-TMP) alone and in combination with various antibiotics on bacterial strains isolated from urinary tract infections (author's transl)].
    Joly B; Chanal M; Sirot D; Cluzel R; Jouan JP
    Pathol Biol (Paris); 1979 Feb; 27(2):117-24. PubMed ID: 382045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of the combination trimethoprim plus sulfamethoxazole compared with that of other chemotherapeutic agents.
    Focht J; Klietmann W; Nösner K
    Arzneimittelforschung; 1988 Aug; 38(8):1085-8. PubMed ID: 3264166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethoprim-resistant Enterobacteriaceae in urinary tract infection.
    Wong CK; Harding GK; Ronald AR; Hoban S
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):54-8. PubMed ID: 1093652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.